Literature DB >> 17023436

Serological tests for visceral leishmaniasis.

Diana N J Lockwood, Shyam Sundar.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17023436      PMCID： PMC1592372          DOI： 10.1136/bmj.38989.567083.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

Review 1.  Laboratory diagnosis of visceral leishmaniasis.

Authors:  Shyam Sundar; M Rai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

2.  Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal.

Authors:  S Rijal; M Boelaert; S Regmi; B M S Karki; D Jacquet; R Singh; M L Chance; F Chappuis; M Hommel; P Desjeux; P Van der Stuyft; D Le Ray; S Koirala
Journal:  Trop Med Int Health       Date:  2004-06       Impact factor: 2.622

3.  Field evaluation of latex agglutination test for detecting urinary antigens in visceral leishmaniasis in Sudan.

Authors:  S H El-Safi; A Abdel-Haleem; A Hammad; I El-Basha; A Omer; H G Kareem; M Boelaert; M Chance; M Hommel
Journal:  East Mediterr Health J       Date:  2003-07       Impact factor: 1.628

Review 4.  A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis.

Authors:  François Chappuis; Suman Rijal; Alonso Soto; Joris Menten; Marleen Boelaert
Journal:  BMJ       Date:  2006-08-01

5.  Rapid accurate field diagnosis of Indian visceral leishmaniasis.

Authors:  S Sundar; S G Reed; V P Singh; P C Kumar; H W Murray
Journal:  Lancet       Date:  1998-02-21       Impact factor: 79.321

6.  Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA.

Authors:  A E Harith; A H Kolk; P A Kager; J Leeuwenburg; F J Faber; R Muigai; S Kiugu; J J Laarman
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

7.  Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region.

Authors:  F Pasquau; J Ena; R Sanchez; J M Cuadrado; C Amador; J Flores; C Benito; C Redondo; J Lacruz; V Abril; J Onofre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

8.  Evaluation of the direct agglutination test (DAT) using freeze-dried antigen for the detection of anti-Leishmania antibodies in stored sera from various patient groups in Ethiopia.

Authors:  L Oskam; J L Nieuwenhuijs; A Hailu
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 May-Jun       Impact factor: 2.184

9.  Purification, characterization of O-acetylated sialoglycoconjugates-specific IgM, and development of an enzyme-linked immunosorbent assay for diagnosis and follow-up of indian visceral leishmaniasis patients.

Authors:  Sumi Bandyopadhyay; Mitali Chatterjee; Santanu Pal; Ross F Waller; Shyam Sundar; Malcolm J McConville; Chitra Mandal
Journal:  Diagn Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.803

Review 10.  Leishmaniasis: current situation and new perspectives.

Authors:  P Desjeux
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.268
View more
  3 in total

1.  Management of visceral leishmaniasis in rural primary health care services in Bihar, India.

Authors:  E Hasker; S P Singh; P Malaviya; R P Singh; R Shankar; M Boelaert; S Sundar
Journal:  Trop Med Int Health       Date:  2010-07       Impact factor: 2.622

2.  Abdominal ultrasound in the diagnostic work-up of visceral leishmaniasis and for detection of complications of spleen aspiration.

Authors:  Rezika Mohammed; Yonathan Gebrewold; Angela Schuster; Helina Fikre; Tigist Mekonnen; Tadele Mulaw; Tadfe Bogale; Florian Vogt; Ermias Diro; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2021-02-16

3.  Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination.

Authors:  Hermali Silva; Achala Liyanage; Theja Deerasinghe; Vasana Chandrasekara; Kalaivani Chellappan; Nadira D Karunaweera
Journal:  PLoS One       Date:  2021-10-22       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.